Whitehawk Therapeutics, Inc. — Director's Dealing 2020

Jun 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aerpio Pharmaceuticals, Inc. (ARPO)
CIK: 0001422142
Period of Report: 2020-06-24

Reporting Person: Dugel Pravin (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-24	Stock Option (Right to Buy)	$1.22	A	52144	Acquired	2030-06-24	Common Stock (52144)	Direct

Footnotes

F1: Options shall vest annually on the earlier of the one year anniversary of the Grant Date or the Company's next annual meeting, subject to director's continued service on the Board at such time.